4.5 Editorial Material

Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders

Journal

EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 30, Issue 1, Pages 1-4

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/13543784.2021.1840550

Keywords

Copper; cytochrome c oxidase; elesclomol; Menkes disease; mitochondria

Funding

  1. National Institutes of Health [R01GM111672]
  2. Welch Foundation [A-1810]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemistry & Molecular Biology

A genome-wide copper-sensitized screen identifies novel regulators of mitochondrial cytochrome c oxidase activity

Natalie M. Garza, Aaron T. Griffin, Mohammad Zulkifli, Chenxi Qiu, Craig D. Kaplan, Vishal M. Gohil

Summary: This study identified novel genetic regulators of mitochondrial copper homeostasis through a genome-wide screen, including subunits of the AP-3 complex and components of the cellular pH-sensing pathway. These genes impact vacuolar acidity, which in turn perturbs mitochondrial copper homeostasis and CcO function. The study provides insights into how vacuolar pH affects mitochondrial respiration through copper homeostasis.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

Choline restores respiration in Psd1-deficient yeast by replenishing mitochondrial phosphatidylethanolamine

Donna M. Iadarola, Alaumy Joshi, Cameron B. Caldwell, Vishal M. Gohil

Summary: Phosphatidylethanolamine (PE) is essential for mitochondrial respiration in yeast, while phosphatidylcholine (PC) can largely be replaced. Choline (Cho) has been shown to rescue respiratory growth of PE-deficient yeast by replenishing mitochondrial PE levels. This rescue mechanism involves the conversion of Cho to PC via the Kennedy pathway and the involvement of enzyme Psd2 in PE biosynthesis.

JOURNAL OF BIOLOGICAL CHEMISTRY (2021)

Article Biochemistry & Molecular Biology

MCU-complex-mediated mitochondrial calcium signaling is impaired in Barth syndrome

Sagnika Ghosh, Mohammad Zulkifli, Alaumy Joshi, Manigandan Venkatesan, Allen Cristel, Neelanjan Vishnu, Muniswamy Madesh, Vishal M. Gohil

Summary: This study demonstrates the importance of mitochondrial phospholipid cardiolipin in the stability and activity of the mitochondrial calcium uniporter (MCU) complex regulatory subunit MICU1 in Barth syndrome patients. The decrease in MICU1 levels disrupts mitochondrial calcium uptake kinetics, leading to the impairment of pyruvate dehydrogenase activation and reducing equivalents generation, ultimately affecting mitochondrial bioenergetics. Defects in mitochondrial calcium signaling may contribute to cardiac and skeletal muscle pathologies in Barth syndrome patients, highlighting a potential therapeutic target for this disorder.

HUMAN MOLECULAR GENETICS (2022)

Review Biochemistry & Molecular Biology

The Role of COA6 in the Mitochondrial Copper Delivery Pathway to Cytochrome c Oxidase

Abhinav B. Swaminathan, Vishal M. Gohil

Summary: Copper is essential for the stability and activity of cytochrome c oxidase (CcO), the terminal enzyme of the mitochondrial respiratory chain. The biogenesis of copper sites in CcO requires evolutionarily conserved proteins that form the mitochondrial copper delivery pathway. Mutations in some of these proteins have been shown to cause fatal infantile human disorders, emphasizing the biomedical significance of understanding copper delivery mechanisms to CcO.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

Elesclomol elevates cellular and mitochondrial iron levels by delivering copper to the iron import machinery

Natalie M. Garza, Mohammad Zulkifli, Vishal M. Gohil

Summary: Copper and iron are essential cofactors for cellular enzymes, and disruption in their homeostasis can lead to severe human disorders. A study found that the investigational anticancer drug ES can deliver copper to mitochondrial cuproenzymes, potentially treating copper deficiency disorders. The study also revealed that ES treatment increases cellular and mitochondrial iron content, independent of the major cellular copper importer but dependent on the iron importer Ftr1 and its partner Fet3. The mechanism by which ES distributes copper in cells and influences iron homeostasis was further investigated.

JOURNAL OF BIOLOGICAL CHEMISTRY (2022)

Article Genetics & Heredity

A yeast suppressor screen links Coa4 to the mitochondrial copper delivery pathway for cytochrome c oxidase

Abhinav B. Swaminathan, Shivatheja Soma, Alison C. Vicary, Mohammad Zulkifli, Harman Kaur, Vishal M. Gohil

Summary: This study identified Coa4 as an essential protein in the copper delivery pathway to the Cu-B site of cytochrome c oxidase. It also revealed the involvement of Coa4 in cellular copper homeostasis.

GENETICS (2022)

Editorial Material Cell Biology

Editorial: Function and formation of mitochondrial metalloproteome

Michal Wasilewski, Vishal M. Gohil, Oleh Khalimonchuk

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Review Endocrinology & Metabolism

Mitochondrial copper in human genetic disorders

Natalie M. Garza, Abhinav B. Swaminathan, Krishna P. Maremanda, Mohammad Zulki Fli, Vishal M. Gohil

Summary: Copper is an essential micronutrient that plays a crucial role in mitochondrial energy metabolism. Copper enters cells through transporters and is distributed to cuproenzymes by chaperones. Mutations in copper transporters and chaperones disrupt copper homeostasis in mitochondria, leading to genetic disorders. Elesclomol, a copper ionophore, shows therapeutic potential for copper deficiency disorders.

TRENDS IN ENDOCRINOLOGY AND METABOLISM (2023)

Article Biochemistry & Molecular Biology

Cardiolipin deficiency leads to the destabilization of mitochondrial magnesium channel MRS2 in Barth syndrome

Alaumy Joshi, Vishal M. Gohil

Summary: Barth syndrome is a debilitating disorder caused by mutations in the TAFAZZIN gene, which is involved in maintaining normal levels of cardiolipin in mitochondrial membranes. A recent study found that in addition to calcium, the levels of magnesium are significantly reduced in Barth syndrome patients. This study also identified a decrease in the abundance of the mitochondrial magnesium influx channel MRS2 in various models of Barth syndrome. The researchers attributed this reduction to the increased turnover of MRS2 in models with cardiolipin deficiency. These findings suggest that perturbation of mitochondrial magnesium homeostasis may contribute to the pathology of Barth syndrome.

HUMAN MOLECULAR GENETICS (2023)

Review Cell Biology

Mitochondrial phospholipid metabolism in health and disease

Alaumy Joshi, Travis H. Richard, Vishal M. Gohil

Summary: Studies on mitochondrial phospholipids have revealed their crucial role in mitochondrial bioenergetics and human health. The composition and function of these phospholipids have been highly conserved, and recent advances in understanding their transport mechanisms have further enhanced our understanding of mitochondrial phospholipid homeostasis. Additionally, disruptions in mitochondrial phospholipid biosynthesis have been linked to various genetic diseases, and promising therapeutic strategies are being developed for these disorders.

JOURNAL OF CELL SCIENCE (2023)

Article Medicine, Research & Experimental

Mitochondrial dysfunction reactivates ?-fetoprotein expression that drives copper-dependent immunosuppression in mitochondrial disease models

Kimberly A. Jett, Zakery N. Baker, Amzad Hossain, Aren Boulet, Paul A. Cobine, Sagnika Ghosh, Philip Ng, Orhan Yilmaz, Kris Barreto, John DeCoteau, Karen Mochoruk, George N. Ioannou, Christopher Savard, Sai Yuan, Osama H. M. H. Abdalla, Christopher Lowden, Byung-Eun Kim, Hai-Ying Mary Cheng, Brendan J. Battersby, Vishal M. Gohil, Scot C. Leary

Summary: We identified a copper-linked signaling circuit activated by disrupted mitochondrial function, resulting in atrophy of the spleen and thymus and a deficiency in peripheral white blood cells. The leukopenia was caused by alpha-fetoprotein, which required copper and the cell surface receptor CCR5 to promote white blood cell death. The upregulation of alpha-fetoprotein in stressed tissue may suppress the immune system, contributing to recurrent or chronic infections in mitochondrial diseases or other disorders with secondary mitochondrial dysfunction.

JOURNAL OF CLINICAL INVESTIGATION (2023)

Article Biochemistry & Molecular Biology

Noncanonical role of singleminded-2s in mitochondrial respiratory chain formation in breast cancer

Steven W. Wall, Lilia Sanchez, Kelly Scribner Tuttle, Scott J. Pearson, Shivatheja Soma, Garhett L. Wyatt, Hannah N. Carter, Ramsey M. Jenschke, Lin Tan, Sara A. Martinez, Philip L. Lorenzi, Vishal M. Gohil, Monique Rijnkels, Weston W. Porter

Summary: Researchers discovered that a metabolism-related protein plays a crucial role in stabilizing breast cancer cell growth, providing insight for the development of treatments to block cancer progression.

EXPERIMENTAL AND MOLECULAR MEDICINE (2023)

Article Biochemistry & Molecular Biology

FDX1 Is Required for the Biogenesis of Mitochondrial Cytochrome c Oxidase in Mammalian Cells

Mohammad Zulkifli, Adriana U. Okonkwo, Vishal M. Gohil

Summary: Ferredoxins (FDXs) are a class of iron-sulfur (Fe-S) proteins that function as electron transfer proteins in various metabolic pathways. This study demonstrates the essential role of FDX1 in mitochondrial respiration and energy production in rat cardiomyocyte cells. FDX1 knockout leads to reduced mitochondrial respiration by decreasing the abundance and assembly of cytochrome c oxidase (CcO), the terminal enzyme of the mitochondrial respiratory chain. FDX1 is also involved in heme a biosynthesis and acts upstream of COX15 in CcO biogenesis.

JOURNAL OF MOLECULAR BIOLOGY (2023)

Review Oncology

Connecting copper and cancer: from transition metal signalling to metalloplasia

Eva J. Ge, Ashley I. Bush, Angela Casini, Paul A. Cobine, Justin R. Cross, Gina M. DeNicola, Q. Ping Dou, Katherine J. Franz, Vishal M. Gohil, Sanjeev Gupta, Stephen G. Kaler, Svetlana Lutsenko, Vivek Mittal, Michael J. Petris, Roman Polishchuk, Martina Ralle, Michael L. Schilsky, Nicholas K. Tonks, Linda T. Vahdat, Linda Van Aelst, Dan Xi, Peng Yuan, Donita C. Brady, Christopher J. Chang

Summary: Copper is a essential nutrient with both beneficial and toxic properties to cells. Recent progress in transition metal signaling has led to new connections between researchers from different disciplines, with potential for translating basic research into clinical therapies for diseases. The relationship between copper and cancer is particularly important, with opportunities for leveraging disease vulnerabilities through copper-dependent signaling pathways.

NATURE REVIEWS CANCER (2022)

No Data Available